Company Description
Aegon Nv (OTC Link: AEGOF) is classified in the insurance - diversified industry within the Financial Services sector and carries a market capitalization of $13.9B.
AEGOF has gained 15.1% over the past year. Shares last traded at $9.21.
This page collects what Stock Titan holds for AEGOF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aegon Nv (AEGOF) stock last closed at $9.21. Over the past 12 months, the stock has gained 15.1%. At a market capitalization of $13.9B, AEGOF is classified as a large-cap stock with approximately 1.5B shares outstanding.
Latest News
SEC Filings
Aegon Nv has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on September 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AEGOF SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Aegon Nv (AEGOF) currently stands at 10.1 million shares, down 22.3% from the previous reporting period, representing 0.8% of the float. Since September 2025, short interest has increased by 370.2%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Aegon Nv (AEGOF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 4.7 to 1000.0 days.
AEGOF Company Profile & Sector Positioning
Aegon Nv (AEGOF) operates in the Insurance - Diversified industry within the broader Financial Services sector and is listed on the OTC Link.